New cancer clinical trial: A Study Evaluating the Safety and Pharmacokinetics of ABBV-744 in Subjects With Advanced Prostate Cancer (CRPC) and Relapsed/Refractory Acute Myeloid Leukemia (AML) Cancer

Published on: December 01, 2017 at 10:00AM
Conditions:   Cancer - Castrate-Resistant Prostate Cancer;   Cancer - Acute Myeloid Leukemia
Intervention:   Drug: ABBV-744
Sponsor:   AbbVie
Not yet recruiting
http://ift.tt/2AOqYFD